NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir

Hayato Uemura,Yoshihito Uchida,Jun-ichi Kouyama,Kayoko Naiki,Shohei Tsuji,Kayoko Sugawara,Masamitsu Nakao,Daisuke Motoya,Nobuaki Nakayama,Yukinori Imai,Tomoaki Tomiya,Satoshi Mochida

NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir

2019

Hayato Uemura
Yoshihito Uchida
Jun-ichi Kouyama
Kayoko Naiki
Shohei Tsuji
Kayoko Sugawara
Masamitsu Nakao
Daisuke Motoya
Nobuaki Nakayama
Yukinori Imai
Tomoaki Tomiya
Satoshi Mochida

Background This study sought to clarify the factors involved in virologic failure in patients with HCV receiving retreatment with glecaprevir/pibrentasvir (GLE/PIB) in real-world practice.

Keywords:

General surgery
NS5A
Diabetes mellitus
Glecaprevir
Internal medicine
VIROLOGIC FAILURE
Medicine
Pibrentasvir
Gastroenterology
Hepatology
Deep sequencing
in patient
Genotype

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations